Modulation of Ets-1 Expression in B Lymphocytes is Dependent on the Antigen Receptor-mediated Activation Signals and Cell Cycle Status

Scandinavian Journal of Immunology

Volumn 77, Issue 2, 2013, Pages 75-83

  Raghunandan, R ^a   Frissora, F W ^a   Muthusamy, N ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD40 ANTIGEN; CYCLIN A; IONOMYCIN; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE S PHASE; DNA SYNTHESIS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; B-LYMPHOCYTES; CALCIUM; CELL CYCLE; CELL LINE; CYCLIN A; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MICE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTORS, ANTIGEN, B-CELL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84872863663     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12012     Document Type: Article

References (38)

1. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 1992;6:975-90.
2. Sementchenko VI, Watson D K. Ets target genes: past, present and future. Oncogene 2000;19:6533-48.
3. Yang B. S., Hauser C. A., Henkel G. et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 1996;16:538-47.
4. Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 1997;14:899-913.
5. Bhat NK, Fisher RJ, Fujiwara S, Ascione R, Papas TS. Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci USA 1987;84:3161-5.
6. Leiden JM, Wang CY, Petryniak B, Markovitz DM, Nabel GJ, Thompson CB. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol 1992;66:5890-7.
7. Ray D, Bosselut R, Ghysdael J, Mattei MG, Tavitian A, Moreau-Gachelin F. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol 1992;12:4297-304.
8. Su GH, Ip HS et al. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med 1996;184:203-15.
9. Su GH, Chen HM, Muthusamy N et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J 1997;16:7118-29.
10. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 1990;61:113-24.
11. Maroulakou IG, Papas TS, Green JE. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 1994;9:1551-65.
12. Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON. Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 1993;177:915-23.
13. Hagman J., Grossched R. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene. Proc Natl Acad Sci USA 1992;89:8889-93.
14. Akbarali Y, Oettgen P, Boltax J, Libermann TA. ELF-1 interacts with and transactivates the IgH enhancer pi site. J Biol Chem 1996;271:26007-12.
15. Rao E, Dang W, Tian G, Sen R. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer. J Biol Chem 1997;272:6722-32.
16. Muller S, Sideras P, Smith CI, Xanthopoulos KG. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Oncogene 1996;13:1955-64.
17. Nelsen B, Tian G, Erman B et al. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. Science 1993;261:82-6.
18. Coffer P, de Jonge M, Mettouchi A, Binetruy B, Ghysdael J, Kruijer W. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 1994;9:911-21.
19. Fleischman LF, Pilaro AM, Murakami K, Kondoh A, Fisher RJ, Papas TS. c-Ets-1 protein is hyperphosphorylated during mitosis. Oncogene 1993;8:771-80.
20. Wasylyk C, Maira SM, Sobieszczuk P, Wasylyk B. Reversion of Ras transformed cells by Ets transdominant mutants. Oncogene 1994;9:3665-73.
21. Mittelstadt PR, DeFranco AL. Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J. Immunol. 1993;150:4822-33.
22. Fisher CL, Ghysdael J, Cambier JC. Ligation of membrane Ig leads to calcium-mediated phosphorylation of the proto-oncogene product, Ets-1. J. Immunol. 1991;146:1743-9.
23. Cowley DO, Graves BJ. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev 2000;14:366-76.
24. Rabault B, Ghysdael J. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J Biol Chem 1994;269:28143-51.
25. Muthusamy N, Baluyut AR, Subbarao B. Differential regulation of surface Ig and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. J. Immunol. 1991;147:2483-92.
26. Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C, Leiden JM. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 1996;379:81-5.
27. May WS Jr, Sahyoun N, Wolf M, Cuatrecasas P. Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes. Nature 1985;317:549-51.
28. Harwood AE, Cambier JC. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1. J. Immunol. 1993;151:4513-22.
29. Hayne C, Tzivion G, Luo Z. Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J Biol Chem 2000;275:31876-82.
30. Reed JC, Tanaka S, Cuddy M. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines. Cancer Res 1992;52:2802-5.
31. De Brabander MJ, Van de Veire RM, Aerts FE, Borgers M, Janssen PA. The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res 1976;36:905-16.
32. Richards JD, Dave SH, Chou CH, Mamchak AA, DeFranco AL. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 2001;166:3855-64.
33. Wright JH, Munar E, Jameson DR et al. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 1999;96:11335-40.
34. Pognonec P, Boulukos KE, Gesquiere JC, Stehelin D, Ghysdael J. Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins. EMBO J 1988;7:977-83.
35. Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995;377:639-42.
36. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991;67:1169-79.
37. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992;11:961-71.
38. Miyazaki Y, Boccuni P, Mao S et al. Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle. J Biol Chem 2001;276:40528-36.